IAS Conference on HIV Science
People with HIV, mpox not at increased risk for hospitalization unless immunosuppressed
People with HIV diagnosed with mpox were not at an increased risk for hospitalization unless they were immunosuppressed, according to findings presented at the International AIDS Society Conference on HIV Science.
Adults with HIV can lower risk for cardiovascular disease with daily statin, study finds
Adults with HIV can lower their risk for serious cardiovascular events like heart attack or stroke by more than one-third if they take a daily statin, a large phase 3 trial found.
Women in study preferred long-acting injectable HIV PrEP over daily pill
Cisgender women preferred long-acting injectable PrEP over taking a daily pill for HIV prevention by a nearly 4-to-1 margin, according to study findings presented at the International AIDS Society conference.
Circumcision may reduce HIV risk among men who have sex with men
Voluntary medical male circumcision can reduce the risk for HIV acquisition among men who have sex with men who primarily practice insertive anal sex, according to the results of a randomized controlled trial conducted in China.
Boys may have easier time controlling HIV than girls, study findings suggest
Five male infants in South Africa who were born with HIV were able to maintain undetectable viral loads for months despite low adherence to ART, according to researchers at the International AIDS Society Conference on HIV Science.
People with HIV did not see large decline in COVID-19 mortality during omicron wave
Compared with their peers, people with HIV experienced a smaller decline in mortality risk from COVID-19 during the omicron wave of the pandemic, researchers reported.
Man remains in treatment-free HIV remission after stem cell transplant
A man has remained in treatment-free HIV remission for nearly 2 years after receiving a stem-cell transplant to treat a rare and aggressive form of leukemia, researchers reported Wednesday.